placeholder image
P. Calhoun All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL. 
    Diabetes Technology & Therapeutics. 2024
  • A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • Assessment of the glucose management indicator using different sampling durations. 
    Diabetes Technology & Therapeutics. 2023
  • Discordance between glucose management indicator and glycated hemoglobin in people without diabetes. 
    Diabetes Technology & Therapeutics. 2023
  • The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring. 
    Diabetes Technology & Therapeutics. 2023
  • A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G. 
    Diabetes Technology & Therapeutics. 2022
  • Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems. 
    Diabetes Technology & Therapeutics. 2022
  • The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial. 
    Diabetes Technology & Therapeutics. 2022
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. 
    Lancet (London, England). 2021
  • Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. 
    JAMA. 2021
  • Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data. 
    Diabetes, Obesity & Metabolism. 2021
  • Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives. 
    Diabetes Technology & Therapeutics. 2021
  • The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin. 
    Diabetes care. 2021
  • Diabetes telehealth solutions: improving self-management through remote initiation of continuous glucose monitoring. 
    Journal of the Endocrine Society. 2020
    • Contact
    full name
  • P. Calhoun
    • Quick Info
     
    Collaboration